Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AMWL 
American Well Corp (AMWL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: AMWL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $9.5
1 Year Target Price $9.5
| 1 | Strong Buy |
| 0 | Buy |
| 8 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -69.71% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/24/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 89.00M USD | Price to earnings Ratio - | 1Y Target Price 9.5 |
Price to earnings Ratio - | 1Y Target Price 9.5 | ||
Volume (30-day avg) 9 | Beta 1.27 | 52 Weeks Range 5.32 - 12.95 | Updated Date 10/25/2025 |
52 Weeks Range 5.32 - 12.95 | Updated Date 10/25/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -8.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-10-29 | When After Market | Estimate -1.46 | Actual - |
Profitability
Profit Margin -46.16% | Operating Margin (TTM) -28.74% |
Management Effectiveness
Return on Assets (TTM) -17.93% | Return on Equity (TTM) -37.62% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -113832204 | Price to Sales(TTM) 0.33 |
Enterprise Value -113832204 | Price to Sales(TTM) 0.33 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA -0.82 | Shares Outstanding 14504796 | Shares Floating 12344559 |
Shares Outstanding 14504796 | Shares Floating 12344559 | ||
Percent Insiders 5.54 | Percent Institutions 44.06 |
Upturn AI SWOT
American Well Corp
Company Overview
History and Background
American Well (Amwell) was founded in 2006 by brothers Ido and Roy Schoenberg. It aimed to provide telehealth services connecting patients with doctors through secure video and audio. The company expanded its platform over time, partnering with healthcare providers, insurers, and employers, and eventually going public in 2020.
Core Business Areas
- Amwell Platform: The Amwell Platform is a comprehensive telehealth solution that enables healthcare providers to offer virtual care services to their patients. It includes video consultations, secure messaging, and remote monitoring capabilities.
- Amwell Medical Group: The Amwell Medical Group is a network of physicians and other healthcare professionals who provide telehealth services directly to patients through the Amwell platform.
- Converge: Converge is Amwell's next generation platform designed to unify healthcare delivery and provide a more seamless virtual care experience.
Leadership and Structure
Amwell is led by CEO Ido Schoenberg. The organizational structure includes departments for technology, marketing, sales, operations, and finance, along with a board of directors.
Top Products and Market Share
Key Offerings
- Amwell Platform: The Amwell Platform facilitates virtual consultations and remote monitoring. Competitors include Teladoc Health, MDLive, and Doctor on Demand. Amwell does not publish exact marketshare for this service, but competition is fierce in the Telehealth platform space. This represents the bulk of Amwell's revenue stream.
- Amwell Medical Group: Provides telehealth services directly to consumers. Competitors are the same as above, plus various smaller telehealth providers. No exact revenue figures are publicly available but represents a decreasing portion of the overall revenue as they want other medical groups to use their platform rather than use their own staff.
- Converge: Amwell's newest offering is Converge, a platform designed to unify healthcare delivery. While it is still early days for this platform, they expect it to be a major revenue generator once current clients start converting. There is not specific data on Converge revenue and marketshare as it is new.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth due to increasing demand for convenient and accessible healthcare solutions, technological advancements, and favorable regulatory changes.
Positioning
Amwell is positioned as a comprehensive telehealth platform provider, partnering with healthcare systems and insurers to integrate virtual care into their existing workflows. They aim to be a platform that helps hospitals and health systems, not just a direct to consumer telemedicine business.
Total Addressable Market (TAM)
The telehealth market is estimated to be worth hundreds of billions of dollars. Amwell is positioned to capture a significant portion of this market through its platform and partnerships.
Upturn SWOT Analysis
Strengths
- Established Platform
- Strong Partnerships
- Comprehensive Solutions
- Experienced Leadership
Weaknesses
- Lack of profitability
- Intense Competition
- High Marketing Costs
- Platform complexity can lead to implementation challenges
Opportunities
- Expanding Telehealth Market
- Growing Demand for Virtual Care
- Strategic Partnerships
- Innovation in remote monitoring
Threats
- Increased Competition
- Regulatory Changes
- Reimbursement Uncertainty
- Data Security Concerns
Competitors and Market Share
Key Competitors
- TDOC
- LVGO
- ONEM
Competitive Landscape
Amwell's advantage lies in its comprehensive platform. Disadvantages include profitability, marketing costs, and competition.
Major Acquisitions
SilverCloud Health
- Year: 2021
- Acquisition Price (USD millions): 257.6
- Strategic Rationale: Expand behavioral health offerings and capabilities
Conversa Health
- Year: 2021
- Acquisition Price (USD millions): 70
- Strategic Rationale: Enhance patient engagement and virtual care coordination.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been strong in terms of revenue, but profits have not increased along with it.
Future Projections: Future projections are highly dependent on market penetration and successful execution of their strategy. Analyst estimates vary widely.
Recent Initiatives: Recent initiatives include launching Converge, expanding partnerships, and focusing on product innovation.
Summary
Amwell is a key player in the growing telehealth industry with a comprehensive platform and strategic partnerships. However, profitability remains a challenge amidst strong competition. They are investing in innovation, particularly with the Converge platform, to drive future growth, but they need to improve profitability or raise more funding. Increased regulation and reimbursement challenges could threaten their business model.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Industry reports
- Analyst estimates
- Company Website
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary depending on the source.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Well Corp
Exchange NYSE | Headquaters Boston, MA, United States | ||
IPO Launch date 2020-09-17 | Chairman & CEO Dr. Ido Schoenberg M.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 877 | Website https://business.amwell.com |
Full time employees 877 | Website https://business.amwell.com | ||
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.